The New York Times @nytimes
A key advisory panel to the FDA rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19. https://t.co/31zhwVxPvo — PolitiTweet.org